Sleep study begins investigating the impact of melatonin on sleep in ADHD

Written by Emily Brown

An international trial aiming to investigate the impact of the hormone melatonin in aiding sleep in children with attention deficit hyperactivity disorder (ADHD) has begun recruiting. Children with ADHD often encounter problems getting to sleep, which can be exacerbated by the medications utilized to abate ADHD symptoms. In collaboration with researchers at Lady Cilento Children’s Hospital in South Brisbane, Jane Nikles from The University of Queensland (both Queensland, Australia) and team are recruiting children aged 6–17 years with a diagnosis of ADHD who are currently receiving stimulants such as Ritalin [Novartis Pharmaceuticals, Surrey, UK] and experiencing sleep troubles. Trial participants...

To view this content, please register now for access

It's completely free